Whilst various genetically modified strains, such as atherosclerosis-prone, apolipoprotein-E (ApoE) knockouts are available for use, current literature typically use wild-type of genetically healthy species of animals [120,130,132,142]. This evidence concerns the gene APOE and atherosclerosis.